TRINETRA › Sectors › Healthcare
Shilpa Medicare Limited (SHILPAMED) — share price, P/E and fundamentals
Shilpa Medicare Limited (NSE: SHILPAMED) closed at ₹955.60 on 30 Oct 2026, +168.4% over one year, against a 52-week range of ₹259.50 – ₹1,095.00.
In the quarter ended 30 Jun 2026 (consolidated, filed 5 Aug 2026) it reported revenue of ₹466 cr and net profit of ₹101 cr, a 21.7% net margin; revenue grew 44.9% and profit grew 83.0% year on year.
Against 65 Healthcare peers on NSE: Net margin higher than 81% of 63 sector peers; PBT margin higher than 56% of 63 sector peers.
Key figures
| Last close | ₹955.60 (30 Oct 2026) |
|---|---|
| Change 1 month / 6 months / 1 year | -5.1% / +130.9% / +168.4% |
| 52-week low – high | ₹259.50 – ₹1,095.00 |
| Quarter revenue | ₹466 cr |
| Quarter net profit | ₹101 cr |
| Net margin | 21.7% |
| Revenue growth (YoY) | +44.9% |
| Profit growth (YoY) | +83.0% |
| Average daily turnover (50 days) | ₹74.1 cr |
Against Healthcare peers
| Metric | SHILPAMED | Peer median | Percentile |
|---|---|---|---|
| Net margin | 21.66 | 12.67 | 81 |
| PBT margin | 19.77 | 17.57 | 56 |
Questions
What were Shilpa Medicare Limited's latest quarterly results?
For the quarter ended 30 Jun 2026, Shilpa Medicare Limited reported revenue of ₹466 cr and net profit of ₹101 cr (consolidated), filed with the exchange on 5 Aug 2026.
What is SHILPAMED's 52-week high and low?
Over the last 52 weeks to 30 Oct 2026, SHILPAMED traded between ₹259.50 and ₹1,095.00.
Other Healthcare stocks
- Sun Pharmaceutical Industries Limited (SUNPHARMA)
- Divi's Laboratories Limited (DIVISLAB)
- Torrent Pharmaceuticals Limited (TORNTPHARM)
- Laurus Labs Limited (LAURUSLABS)
- Zydus Lifesciences Limited (ZYDUSLIFE)
- Apollo Hospitals Enterprise Limited (APOLLOHOSP)
- Dr. Reddy's Laboratories Limited (DRREDDY)
- Cipla Limited (CIPLA)
- Mankind Pharma Limited (MANKIND)
- Aurobindo Pharma Limited (AUROPHARMA)
- Lupin Limited (LUPIN)
- Max Healthcare Institute Limited (MAXHEALTH)
Source: consolidated SEBI Integrated Filing for the quarter ended 30 Jun 2026 and NSE daily closes. Open the interactive terminal view for charts and the full statements.
TRINETRA is a research and education tool. Nothing on this site is investment advice or a recommendation to buy or sell any security. Markets carry risk; do your own research and consult a SEBI-registered adviser before investing. Figures are as filed with NSE/SEBI and as of the dates shown; they are not live prices.